STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications
Top Cited Papers
- 16 August 2001
- journal article
- Published by Springer Nature in Oncogene
- Vol. 20 (36), 5054-5058
- https://doi.org/10.1038/sj.onc.1204704
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.Keywords
This publication has 24 references indexed in Scilit:
- Effect of the Tyrosine Kinase Inhibitor STI571 in a Patient with a Metastatic Gastrointestinal Stromal TumorNew England Journal of Medicine, 2001
- Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571Oncogene, 2000
- KIT Extracellular and Kinase Domain Mutations in Gastrointestinal Stromal TumorsThe American Journal of Pathology, 2000
- Mutations of c-kit JM domain are found in a minority of human gastrointestinal stromal tumorsOncogene, 1999
- Mutations in Exon 11 of c-Kit Occur Preferentially in Malignant versus Benign Gastrointestinal Stromal Tumors and Do Not Occur in Leiomyomas or LeiomyosarcomasThe American Journal of Pathology, 1999
- Expression of Kit in neurofibromin-deficient human Schwann cells: role in Schwann cell hyperplasia associated with Type 1 NeurofibromatosisOncogene, 1998
- Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal TumorsScience, 1998
- Gastrointestinal Stromal Tumours: An UpdateSarcoma, 1998
- Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cellsNature Medicine, 1996
- CD19 of B Cells as a Surrogate Kinase Insert Region to Bind Phosphatidylinositol 3-KinaseScience, 1993